Skip to main content

Table 2 Baseline laboratory data of the study patients with and without CIN

From: Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention

Characteristics

Patients without CIN

(n = 189)

Patients with CIN

(n = 19)

P value

TC (mmol/L)

3.79 ± 0.93

3.82 ± 0.88

0.97

TG (mmol/L)

1.67 ± 1.09

1.51 ± 0.82

0.68

HDL (mmol/L)

0.95 ± 0.29

0.84 ± 0.21

0.19

LDL-C(mmol/L)

2.35 ± 0.84

2.49 ± 0.95

0.75

FBG (mmol/L)

6.21 ± 2.74

8.06 ± 2.72

< 0.01

Scr (μmol/L)

88.82 ± 21.13

119.89 ± 40.81

<0.01

> 124umol/L

13(6.88%)

7(36.84%)

< 0.01

Hs-CRP (mg/L)

7.90 ± 14.14

15.42 ± 13.99

< 0.01

Urinary albumin (g/24 h)

0.26 ± 0.57

0.47 ± 0.82

0.12

Hemoglobin (g/L)

134.24 ± 16.22

125.47 ± 20.40

0.087

UAPN (ng/ml)

10.29 ± 3.04

17.15 ± 12.36

< 0.01

eGFR(ml/min/1.73m2)

64.14 ± 16.55

49.57 ± 19.03

< 0.01

< 60 ml/min/1.73m2 n (%)

82(43.39%)

14(73.68%)

0.01

  1. Data are mean ± standard deviation. TG Triglyceride, TC Total cholesterol, HDL High density lipoprotein, LDL-C Low-density lipoprotein cholesterol, FBG Fasting blood-glucose, UAPN Urinary adiponectin, Scr Serum creatinine, Hs-CRP High-sensitivity C-reactive protein, eGFR Estimated glomerular filtration rate, CIN Contrast-induced nephropathy